617 related articles for article (PubMed ID: 18586310)
1. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2008 Sep; 110(3):345-53. PubMed ID: 18586310
[TBL] [Abstract][Full Text] [Related]
2. Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery.
Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2009 Apr; 113(1):75-82. PubMed ID: 19171373
[TBL] [Abstract][Full Text] [Related]
3. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
Chan JK; Lin YG; Loizzi V; Ghobriel M; DiSaia PJ; Berman ML
J Reprod Med; 2003 Oct; 48(10):756-60. PubMed ID: 14619640
[TBL] [Abstract][Full Text] [Related]
4. Is there any possibility of fertility-sparing surgery in patients with clear-cell carcinoma of the ovary?
Kajiyama H; Shibata K; Suzuki S; Ino K; Yamamoto E; Mizuno K; Sakakibara K; Matsuzawa K; Takeda A; Kinoshita Y; Kawai M; Nagasaka T; Nawa A; Kikkawa F
Gynecol Oncol; 2008 Dec; 111(3):523-6. PubMed ID: 18538833
[TBL] [Abstract][Full Text] [Related]
5. Fertility-sparing surgery in young women with invasive epithelial ovarian cancer.
Kajiyama H; Shibata K; Suzuki S; Ino K; Nawa A; Kawai M; Nagasaka T; Kikkawa F
Eur J Surg Oncol; 2010 Apr; 36(4):404-8. PubMed ID: 20116965
[TBL] [Abstract][Full Text] [Related]
6. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d'Oncologie Gynécologique).
Morice P; Leblanc E; Rey A; Baron M; Querleu D; Blanchot J; Duvillard P; Lhommé C; Castaigne D; Classe JM; Bonnier P;
Hum Reprod; 2005 May; 20(5):1379-85. PubMed ID: 15817592
[TBL] [Abstract][Full Text] [Related]
7. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
[TBL] [Abstract][Full Text] [Related]
8. The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study.
Chan JK; Tian C; Fleming GF; Monk BJ; Herzog TJ; Kapp DS; Bell J
Gynecol Oncol; 2010 Mar; 116(3):301-6. PubMed ID: 19945740
[TBL] [Abstract][Full Text] [Related]
9. Oncologic and reproductive outcomes in patients with advanced-stage borderline ovarian tumors.
Song T; Choi CH; Kim HJ; Lee W; Lee YY; Kim TJ; Lee JW; Bae DS; Kim BG
Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):204-8. PubMed ID: 21306816
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic fertility-sparing staging in unexpected early stage ovarian malignancies.
Muzii L; Palaia I; Sansone M; Calcagno M; Plotti F; Angioli R; Panici PB
Fertil Steril; 2009 Jun; 91(6):2632-7. PubMed ID: 18555237
[TBL] [Abstract][Full Text] [Related]
11. Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer.
Borgfeldt C; Iosif C; Måsbäck A
Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):110-4. PubMed ID: 16859821
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection.
Satoh T; Hatae M; Watanabe Y; Yaegashi N; Ishiko O; Kodama S; Yamaguchi S; Ochiai K; Takano M; Yokota H; Kawakami Y; Nishimura S; Ogishima D; Nakagawa S; Kobayashi H; Shiozawa T; Nakanishi T; Kamura T; Konishi I; Yoshikawa H
J Clin Oncol; 2010 Apr; 28(10):1727-32. PubMed ID: 20194858
[TBL] [Abstract][Full Text] [Related]
13. Platinum-based chemotherapy of high-risk stage I epithelial ovarian cancer following comprehensive surgical staging.
Rubin SC; Wong GY; Curtin JP; Barakat RR; Hakes TB; Hoskins WJ
Obstet Gynecol; 1993 Jul; 82(1):143-7. PubMed ID: 8515915
[TBL] [Abstract][Full Text] [Related]
14. For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?
Dizon DS; Restivo A; Lomme M; Charbonneau N; Brard L; Hughes T; Weitzen S; Legare R; Granai CO; Disilvestro P
Am J Clin Oncol; 2008 Feb; 31(1):39-42. PubMed ID: 18376226
[TBL] [Abstract][Full Text] [Related]
15. Preservation of ovarian function, reproductive ability and emotional attitudes in patients with malignant ovarian tumors.
Zanagnolo V; Sartori E; Trussardi E; Pasinetti B; Maggino T
Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):235-43. PubMed ID: 15921842
[TBL] [Abstract][Full Text] [Related]
16. Recurrence and prognostic factors in borderline ovarian tumors.
Ayhan A; Guvendag Guven ES; Guven S; Kucukali T
Gynecol Oncol; 2005 Sep; 98(3):439-45. PubMed ID: 16009407
[TBL] [Abstract][Full Text] [Related]
17. Fertility preservation in young women with epithelial ovarian cancer.
Wright JD; Shah M; Mathew L; Burke WM; Culhane J; Goldman N; Schiff PB; Herzog TJ
Cancer; 2009 Sep; 115(18):4118-26. PubMed ID: 19670446
[TBL] [Abstract][Full Text] [Related]
18. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
Gotlieb WH; Flikker S; Davidson B; Korach Y; Kopolovic J; Ben-Baruch G
Cancer; 1998 Jan; 82(1):141-6. PubMed ID: 9428490
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
[TBL] [Abstract][Full Text] [Related]
20. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study.
Fauvet R; Poncelet C; Boccara J; Descamps P; Fondrinier E; Daraï E
Fertil Steril; 2005 Feb; 83(2):284-90; quiz 525-6. PubMed ID: 15705364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]